Position in CNSY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$332,797
+$4,946 QoQ
Shares Held
76,155
-96.2% QoQ
Ownership
1.00%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 22 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CNSY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,764,044 across 520 Biotechnology names. CNSY ranks #377 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in CNSY
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $332,797 | 76,155 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $327,851 | 2,016,314 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $718,651 | 1,402,794 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $556,018 | 813,250 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $17,798 | 51,176 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $54,205 | 57,053 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $66,872 | 58,150 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $79,239 | 54,274 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $68,572 | 46,648 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $52,819 | 29,263 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $46,452 | 26,543 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $35,567 | 26,543 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $34,354 | 17,007 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $73,992 | 255,148 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $81,802 | 258,052 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $115,004 | 258,437 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $139,581 | 258,437 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $258,437 | 258,437 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $271,358 | 258,437 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $493,614 | 258,437 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $334,830 | 130,793 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||